Interestingly, IFN-γ-induced CSC differentiation concomitantly enhances tumor susceptibility to chemotherapy, suggesting NK cell-based therapies can be combined with other therapeutic strategies for more effective clinical outcomes (36, 37). Here, IFNG is linked to neoplasm.